95 related articles for article (PubMed ID: 10419050)
41. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
[TBL] [Abstract][Full Text] [Related]
42. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
[TBL] [Abstract][Full Text] [Related]
43. Interferon-gamma treatment of metastasized malignant melanoma.
Haase KD; Lange OF; Scheef W
Anticancer Res; 1987; 7(3 Pt B):335-6. PubMed ID: 3115173
[TBL] [Abstract][Full Text] [Related]
44. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
45. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
46. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity.
Nemunaitis J; Cunningham C; Buchanan A; Blackburn A; Edelman G; Maples P; Netto G; Tong A; Randlev B; Olson S; Kirn D
Gene Ther; 2001 May; 8(10):746-59. PubMed ID: 11420638
[TBL] [Abstract][Full Text] [Related]
47. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
48. Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma.
Propper DJ; Chao D; Braybrooke JP; Bahl P; Thavasu P; Balkwill F; Turley H; Dobbs N; Gatter K; Talbot DC; Harris AL; Ganesan TS
Clin Cancer Res; 2003 Jan; 9(1):84-92. PubMed ID: 12538455
[TBL] [Abstract][Full Text] [Related]
49. Generation of a systemic antitumor response with regional intratumoral injections of interferon gamma retroviral vector.
Karavodin LM; Robbins J; Chong K; Hsu D; Ibanez C; Mento S; Jolly D; Fong TC
Hum Gene Ther; 1998 Oct; 9(15):2231-41. PubMed ID: 9794207
[TBL] [Abstract][Full Text] [Related]
50. Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma.
Braybrooke JP; Slade A; Deplanque G; Harrop R; Madhusudan S; Forster MD; Gibson R; Makris A; Talbot DC; Steiner J; White L; Kan O; Naylor S; Carroll MW; Kingsman SM; Harris AL
Clin Cancer Res; 2005 Feb; 11(4):1512-20. PubMed ID: 15746054
[TBL] [Abstract][Full Text] [Related]
51. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
Triozzi PL; Strong TV; Bucy RP; Allen KO; Carlisle RR; Moore SE; Lobuglio AF; Conry RM
Hum Gene Ther; 2005 Jan; 16(1):91-100. PubMed ID: 15703492
[TBL] [Abstract][Full Text] [Related]
52. Intratumoral delivery of an interferon gamma retrovirus-producing cells inhibits growth of a murine melanoma by a non-immune mechanism.
Yu D; Thomas-Tikhonenko A
Cancer Lett; 2001 Nov; 173(2):145-54. PubMed ID: 11597789
[TBL] [Abstract][Full Text] [Related]
53. Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma.
Dummer R; Rochlitz C; Velu T; Acres B; Limacher JM; Bleuzen P; Lacoste G; Slos P; Romero P; Urosevic M
Mol Ther; 2008 May; 16(5):985-94. PubMed ID: 18388930
[TBL] [Abstract][Full Text] [Related]
54. In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.
Müller JM; Wissemann J; Meli ML; Dasen G; Lutz H; Heinzerling L; Feige K
Schweiz Arch Tierheilkd; 2011 Nov; 153(11):509-13. PubMed ID: 22045456
[TBL] [Abstract][Full Text] [Related]
55. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
[TBL] [Abstract][Full Text] [Related]
56. Construction of retroviral vectors to induce a strong expression of human class interferon gene in human hepatocellular carcinoma cells in vitro.
Cao GW; Jun-Gao ; Du P; Qi ZT; Kong XT
World J Gastroenterol; 1997 Sep; 3(3):139-42. PubMed ID: 27239126
[TBL] [Abstract][Full Text] [Related]
57. Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy.
Long Z; Lu P; Grooms T; Mychkovsky I; Westley T; Fitzgerald T; Sharma-Chibber S; Shand N; McGarrity G; Otto E
Hum Gene Ther; 1999 Mar; 10(5):733-40. PubMed ID: 10210141
[TBL] [Abstract][Full Text] [Related]
58. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses.
Heinzerling LM; Feige K; Rieder S; Akens MK; Dummer R; Stranzinger G; Moelling K
J Mol Med (Berl); 2001; 78(12):692-702. PubMed ID: 11434722
[TBL] [Abstract][Full Text] [Related]
59. A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma.
Seigler HF; Darrow TL; Abdel-Wahab Z; Gangavalli R; Barber J
Hum Gene Ther; 1994 Jun; 5(6):761-77. PubMed ID: 7948138
[No Abstract] [Full Text] [Related]
60. Gene therapy for the treatment of metastatic breast cancer by in vivo transduction with breast-targeted retroviral vector expressing antisense c-fos RNA.
Holt JT; Arteaga CB; Robertson D; Moses HL
Hum Gene Ther; 1996 Jul; 7(11):1367-80. PubMed ID: 8818724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
